Manufacturing review of the cangaroo envelope device history record for the reported lot shows that all packaged and labeled units were quality released to distribution on 04/17/2020 having met all internal qc acceptance requirements.
All sterilization processing records and bioburden testing indicate a successful sterilization cycle and passing results of product lal and sterility samples allowing the subassembly lot to be released for further packaging and labeling having met all criteria for release.
There were no non-conformances during manufacturing or sterilization potentially impacting the final acceptance of this manufacturing lot.
In lieu of a request for the oem supplier dhr review, it is noted that aziyo processes the non-sterile envelope materials including cutting, suturing, packaging and sterilizing the product.
The reason for the explantation of the aziyo device is was related to a tuning issue with the implanted cied and device leads resulting in high pacing thresholds which would potentially decrease battery life.
A replacement device and cangaroo envelope were implanted following removal.
Device tuning issues are a recognized procedural complication associated with cied implantation, and not associated with usage of the cangaroo envelope.
Should aziyo receive any additional details related to this event, a supplemental report will be filed.
|